Breitner J. (2011). Apolipoprotein e, Alzheimer's disease, and amyloid: do we have the cart before the horse?, J Alzheimers Dis, 23(1), 171-172. En savoir plus.

Breitner J. (2011). Further evidence for vascular mediation of Alzheimer's dementia pathogenesis?, Biol Psychiatry, 70(2), 113-114. En savoir plus.

Breitner J., Baker L.D., Montine T.J., Meinert C.L., Lyketsos C.G., Ashe K.H., Brandt J., Craft S., Evans D.E., Green R.C., Ismail M.S., Martin B.K., Mullan M.J., Sabbagh M., Tariot P.N. (2011). Extended results of the Alzheimer's disease anti-inflammatory prevention trial, Alzheimers Dement, 7(4), 402-411. En savoir plus.

Dublin S., Anderson M. L., Haneuse S. J., Heckbert S. R., Crane P. K., Breitner J., McCormick W., Bowen J. D., Teri L., McCurry S. M., Larson E. B. (2011). Atrial fibrillation and risk of dementia: a prospective cohort study, J Am Geriatr Soc, 59(8), 1369-75. En savoir plus.

Gray S.L., Walker R., Dublin S., Haneuse S., Crane P.K., Breitner J., Bowen J., McCormick W., Larson E.B. (2011). Histamine-2 receptor antagonist use and incident dementia in an older cohort, J Am Geriatr Soc, 59(2), 251-257. En savoir plus.

Kauwe J. S., Cruchaga C., Karch C. M., Sadler B., Lee M., Mayo K., Latu W., Su'a M., Fagan A. M., Holtzman D. M., Morris J. C., Breitner J., Alzheimer's Disease Neuroimaging Initiative, Goate A. M. (2011). Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease, PLoS One, 6(2), e15918. En savoir plus.

Mayeux R., Reitz C., Brickman A.M., Haan M.N., Manly J.J., Glymour M.M., Weiss C.C., Yaffe K., Middleton L., Hendrie H.C., Warren L.H., Hayden K.M., Welsh-Bohmer K.A., Breitner J., Morris J.C. (2011). Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1, Alzheimers Dement, 7(1), 15-34. En savoir plus.

McEvoy L. K., Holland D., Hagler D. J., Fennema-Notestine C., Brewer J. B., Dale A. M., Breitner J., Alzheimer's Disease Neuroimaging Initiative (2011). Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis, Radiology, 259(3), 834-43. En savoir plus.

Norton M. C., Smith K. R., Ostbye T., Tschanz J. T., Schwartz S., Corcoran C., Breitner J., Steffens D. C., Skoog I., Rabins P. V., Welsh-Bohmer K. A., Cache County Investigators (2011). Early parental death and remarriage of widowed parents as risk factors for Alzheimer disease: the Cache County study, Am J Geriatr Psychiatry, 19(9), 814-24. En savoir plus.

Tosun D., Schuff N., Mathis C. A., Jagust W., Weiner M. W., Breitner J., Alzheimer's Disease NeuroImaging Initiative (2011). Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment, Brain, 134(Pt 4), 1077-88. En savoir plus.

Treiber K.A., Carlson M.C., Corcoran C., Norton M.C., Breitner J., Piercy K.W., Deberard M.S., Stein D., Foley B., Welsh-Bohmer K.A., Frye A., Lyketsos C.G., Tschanz J.T. (2011). Cognitive Stimulation and Cognitive and Functional Decline in Alzheimer's Disease: The Cache County Dementia Progression Study, J Gerontol B Psychol Sci Soc Sci. En savoir plus.

Tschanz J.T., Corcoran C.D., Schwartz S., Treiber K., Green R.C., Norton M.C., Mielke M.M., Piercy K., Steinberg M., Rabins P.V., Leoutsakos J.M., Welsh-Bohmer K.A., Breitner J., Lyketsos C.G. (2011). Progression of Cognitive, Functional, and Neuropsychiatric Symptom Domains in a Population Cohort With Alzheimer Dementia: The Cache County Dementia Progression Study, Am J Geriatr Psychiatry, 19(6), 532-542. En savoir plus.